1Ostermann H.Antithrombin Ⅲ in Sepsis.New evidences and open questions[J].Minerva Anestesiol,2002,68(5):445
2Eisele B,Lamy M,Thijs LG,et al.Antithrombin Ⅲ in patients with severe sepsis.A randomized,placebo-controlled,double-blind multicenter trial plus a meta-analysis on all randomized,placebo-controlled,double-blind trials with antithrombin Ⅲ in severe sepsis[J].Intensive Care Med,1998,24(7):663
3Ilias W,List W,Decruyenaere J,et al.Antithrombin Ⅲ in patients with severe sepsis:a pharmacokinetic study[J].Intensive Care Med,2000,26(6):704
4Bennett JM.World Health Organization classification of the acute leukemias and myelodysplastic syndrome[J].Int J Hematol,2000,72(2):131
5Higuchi T,Shimizu T,Mori H,et al.Coagulation patterns of disseminated intravascular coagulation in acute promyelocytic leukemia[J].Hematol Oncol,1997,15(4):209
6Dombret H,Scrobohaci ML,Ghorra P,et al.Coagulation disorders associated with acute promyelocytic leukemia:corrective effect of all-transreinoic acid treatment.Leukemia,1993,7(1):2
7Redens TB,Emerson TE Jr.Antithrombin-Ⅲ treatment limits disseminated intravascular coagulation in endotoxemia[J].Circ Shock,1989,28(1):49
5Van Boven H H, Lane D A. Antithrombin and its inherited deficiency states [J]. Semin Hematol, 1997, 34(3): 188-204.
6Kuhle S, Lane D A, Jochmanns K, et al. Homozygous antithrombin deficiency typeⅡ (99Leu to Phe mutation) and childhood thromboembolism [J]. Thromb Haemost, 2001, 86(4): 1007-1011.
7Picard V, Dautzenberg M D, Villoutreix B O, et al. Antithrombin Phe229Leu: a new homozygous variant leading to spontaneous antithrombin polymerization in vivo associated with severe childhood thrombosis [J]. Blood, 2003, 102(3): 919-925.
8Lane D A, Bayston T, Olds R J, et al. Antithrombin mutation database: 2nd (1997) update, for the plasma coagulation inhibitors subcommittee of the scientific and standardization committee of the international society on thrombosis and haemostasis [J]. Thromb Haemost, 1997, 77(1): 197-211.
9Kurihara M, Watanabe K, Inoue S, et al. Characterization of two novel mutations of the antithrombin gene observed in Japanese thrombophilic patients[J]. Thromb Res, 2005, 115(5): 351-358.
10Grira M, Ben- Jemaa H, Lammouchi T, et al. Klippel-Trenaunay syndrome associated with antithrombin Ⅲ deficiency [J]. Rev Neurol, 2008,164(10): 855-858.
